Company profile: Baylis Medical
1.1 - Company Overview
Company description
- Provider of high-technology cardiology, endovascular, and oncology products, specializing in RF transseptal access and puncture systems that create controlled perforations in cardiac and vascular tissues. Products include NRG RF Transseptal Kit and Needle, SupraCross RF Transseptal Solution, VersaCross steerable access solutions, and SureFlex steerable guiding sheaths.
Products and services
- VersaCrossâ„¢ Steerable Access Solution: Delivers exchangeless access-to-delivery of left heart ablation devices with precision steering for transseptal procedures
- NRGâ„¢ RF Transseptal Kit: Produces RF-enabled left-heart access via a radiofrequency needle-based workflow, including transseptal needle, guiding sheath, and optional pigtail wire
- SupraCrossâ„¢ RF Transseptal Solution: Delivers steerable transseptal access by combining a sheath with an RF wire to cross the septum
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Baylis Medical
Lamed
HQ: Germany
Website
- Description: Provider of a vascular and cardiovascular product market access platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lamed company profile →
nContact
HQ: United States
Website
- Description: Provider of medical devices supporting endoscopic treatments for heart rhythm disorders and arrhythmias, including atrial fibrillation (AF). Offers the Numeris Coagulation System with VisiTrax, integrating suction, perfusion, and RF energy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full nContact company profile →
Gemphire Therapeutics
HQ: United States
Website
- Description: Provider of Gemcabene, an LDL cholesterol-lowering medication, which it manufactures and markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gemphire Therapeutics company profile →
HeartHero
HQ: United States
Website
- Description: Provider of portable automated external defibrillator technology and companion mobile app. HeartHero's Elliot AED is designed for non-medical users and offers audio/visual prompts, multilingual support, and connectivity for remote monitoring and post-event data access. The HeartHero App connects to the AED to monitor device status, manage settings, access training videos, and order replacement supplies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HeartHero company profile →
GB Sciences
HQ: United States
Website
- Description: Provider of research and biotechnical development focused on plant-based therapeutics, including the PhAROS AI drug discovery platform to identify and predict active ingredients; therapies for Parkinson’s disease (animal proof-of-concept, US patent); COVID-related cytokine release syndrome therapies (positive proof-of-concept); and oral nanoparticle pain therapeutics (US patent, ongoing animal studies).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GB Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Baylis Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Baylis Medical
2.2 - Growth funds investing in similar companies to Baylis Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Baylis Medical
4.2 - Public trading comparable groups for Baylis Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →